LLY Clears Major Obesity Trial: Get Exposure in THNR

Weight loss drugs have been a big growth area in pharmaceuticals since GLP-1s hit the scene. This booming market has also breathed new life into companies like Eli Lilly (LLY), turning the stock into a must-have for many equity holdings.
Open original source